Renaissance Technologies’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-1,310,913
Closed -$105M 3607
2016
Q4
$105M Buy
+1,310,913
New +$104M 0.17% 108
2016
Q3
Sell
-150,000
Closed -$11.7M 3612
2016
Q2
$11.7M Sell
150,000
-1,770,213
-92% -$126M 0.02% 1043
2016
Q1
$106M Buy
1,920,213
+1,114,100
+138% +$60.7M 0.2% 75
2015
Q4
$49.8M Buy
806,113
+540,300
+203% +$34.1M 0.11% 215
2015
Q3
$16.8M Sell
265,813
-5,800
-2% -$414K 0.04% 588
2015
Q2
$19.8M Buy
271,613
+68,500
+34% +$4.95M 0.05% 547
2015
Q1
$13.3M Sell
203,113
-541,600
-73% -$36M 0.03% 789
2014
Q4
$48.4M Buy
744,713
+129,000
+21% +$8.31M 0.12% 184
2014
Q3
$37M Buy
615,713
+99,700
+19% +$6.51M 0.1% 223
2014
Q2
$35.7M Buy
+516,013
New +$33.5M 0.08% 269
2013
Q3
Sell
-316,813
Closed -$14.5M 3051
2013
Q2
$14.5M Buy
+316,813
New +$13.7M 0.04% 572

Other funds holding STJ

Renaissance Technologies's STJ Position: Q1 2017 in Review

Renaissance Technologies sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 1,310,913 shares — an estimated $105M sold.

Renaissance Technologies first reported a position in STJ in Q2 2013 and held it in 11 quarters. The position peaked at $106M in Q1 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Renaissance Technologies reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Renaissance Technologies sold 1,310,913 St Jude Medical shares in Q1 2017, an estimated $105M.
  • Renaissance Technologies first reported a position in St Jude Medical in Q2 2013 and held it in 11 quarters.
  • Renaissance Technologies's St Jude Medical position peaked at $106M in Q1 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.